Skip to content
glp1.howSign in

How GLP-1 medications affect men vs. women: what the sex differences actually are

The same GLP-1 medication doesn't act quite the same in men and women. On average women lose more weight, get more side effects, and even absorb more of the drug at the same body weight — differences driven partly by estrogen and testosterone. Here's what the research shows about sex differences in weight loss, tolerability, blood sugar, and biology, and what it means for what you should expect.

Updated Jul 19, 2026Evidence-backed

In the STEP trials of semaglutide, women lost markedly more weight than men on the same drug — 14.0% versus 8.0% of body weight in one trial, 16.2% versus 9.3% in another (Börchers & Skibicka, Endocrinology, 2024, DOI (external link), via PubMed). GLP-1 medications aren't sex-neutral. They tend to work harder in women, come with more side effects in women, and are even absorbed differently between the sexes — and some of that traces to estrogen and testosterone. Here's what the evidence actually shows, and what it means for what you should expect.

Women tend to lose more weight

Across GLP-1 analogs, women lose more weight than men on average. In the semaglutide STEP program the gap was consistent: 14.0% vs 8.0% (STEP 1), 7.5% vs 4.6% (STEP 2), and 16.2% vs 9.3% (STEP 4), women versus men respectively (Börchers & Skibicka, Endocrinology, 2024, DOI (external link), via PubMed).

The obvious guess — women are smaller, so a standard dose goes further — isn't the whole story. At the same body weight, women had about 32% higher drug exposure than men on liraglutide, and the review notes that even women who weighed more than the men still lost more. So it's not simply body size; the drug appears to do more per milligram in women.

Side effects hit women harder

The flip side of a stronger response is worse tolerability. Women report and discontinue for side effects considerably more often:

  • Nearly 50% more women than men discontinued treatment overall.
  • Twice as many women stopped specifically because of gastrointestinal side effects.
  • Adverse-effect reports ran 28% higher in women for liraglutide and 41% higher for dulaglutide (Börchers & Skibicka, Endocrinology, 2024, DOI (external link), via PubMed).

This is a practical, not just statistical, point: the same titration schedule may feel harder for a woman, and slowing the dose climb or leaning harder on nausea strategies can be the difference between staying on the medication and quitting. Our guides on managing nausea and when a prescriber might slow your titration are especially relevant here.

Blood sugar: a smaller, less consistent gap

For blood-sugar control (HbA1c), the sex difference is less consistent than it is for weight — though where a difference shows up, it again tends to favor women. Notably, older postmenopausal women don't show the pronounced response that younger women do, one of several clues that estrogen is part of the mechanism (Börchers & Skibicka, Endocrinology, 2024, DOI (external link), via PubMed).

Why sex matters here: estrogen and testosterone

The differences aren't random — sex hormones interact directly with the GLP-1 system:

  • Estrogen amplifies GLP-1's effect on appetite. In lab studies, estrogen enhances GLP-1's action on food-motivated behavior, removing estrogen (ovariectomy in animals) blunts the response, and a designed GLP-1–estrogen combination produced synergistic weight loss. Women also secrete more of their own GLP-1 in the luteal phase of the menstrual cycle than the follicular phase. Together these help explain both the bigger effect in women and why it fades after menopause.
  • Testosterone works on the same pathway in men. Androgens like dihydrotestosterone amplify the incretin effect of GLP-1 and increase GLP-1 receptor expression, a male-side counterpart to the estrogen story (Börchers & Skibicka, Endocrinology, 2024, DOI (external link), via PubMed).

One more social difference: uptake skews female, with women making up over 75% of the youngest (18–25) patients taking these medications.

The questions each sex should be asking are different, too

Beyond how the drug behaves, men and women face genuinely different considerations on a GLP-1:

  • For men, the standouts are testosterone (weight loss often raises it) and fertility (GLP-1s tend to preserve it, unlike testosterone therapy) — covered in men's health on a GLP-1.
  • For women, the front-of-mind issues are contraception and pregnancy (these drugs can undercut the pill and restore fertility, and aren't safe in pregnancy) and PCOS — covered in women's health on a GLP-1.

What this means for you

A few honest caveats. These are averages from groups, not predictions about any one person — plenty of men are strong responders and plenty of women tolerate the medication easily. Standard doses are not sex-adjusted on the label, so this isn't a reason to change your dose on your own; it's context for setting expectations and for advocating on side effects. The universal advice doesn't change by sex either: protect muscle with resistance training and adequate protein while you lose weight. Where sex does usefully change things is anticipation — women may want to plan for a rockier tolerability curve and a stronger weight response, and both men and women benefit from knowing the hormone questions that are specifically theirs.

The bottom line

Men and women get real, measurable differences from the same GLP-1: women tend to lose more weight and have higher drug exposure but also more side effects and discontinuations, while the blood-sugar gap is smaller and fades after menopause — patterns that estrogen and testosterone help explain. None of it rewrites the dose on the label, but it does mean your experience is partly predictable from a variable no one used to account for, and it's worth bringing into the conversation with your prescriber.

This article is general education, not medical advice. Sex differences here are group averages and don't dictate any individual's dose or response — decisions about dosing and side effects belong with your prescriber. Research findings above are attributed to PubMed-indexed articles with DOI links.

sex-differencesmenwomenweight-lossside-effectsestrogentestosteronesupportive-health

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Do women lose more weight than men on a GLP-1?

    On average, yes. In the semaglutide STEP trials women lost markedly more — for example 14.0% vs 8.0% of body weight in one trial and 16.2% vs 9.3% in another, women versus men. And it isn't just because women are smaller: at the same body weight, women had about 32% higher drug exposure. These are group averages, though — plenty of individual men are strong responders.

  • Why do women get more side effects on a GLP-1?

    Women report adverse effects more often and discontinue treatment more — nearly 50% more women stopped overall in the research, and about twice as many stopped specifically because of GI side effects. It appears tied to the same reasons women get a stronger overall response, including higher drug exposure. Practically, it can mean a woman benefits more from a slower dose climb and active nausea management to stay on the medication.

  • Why does sex change how a GLP-1 works?

    Sex hormones interact directly with the GLP-1 system. Estrogen amplifies GLP-1's effect on appetite, which helps explain both the larger response in women and why it's less pronounced after menopause. Testosterone works on the same pathway in men, amplifying the incretin effect. So the differences aren't random — they track real biology.

  • Should men and women take different GLP-1 doses?

    Not on your own — standard doses are not sex-adjusted on the label, and this research is context for setting expectations, not a reason to change your dose. What it does suggest is that women may want to anticipate a stronger weight response but a rockier tolerability curve, and to advocate for slower titration or side-effect support if needed. Any dosing change is a conversation with your prescriber.

  • Are the health questions different for men and women on a GLP-1?

    Yes. For men, the standout issues are testosterone (weight loss often raises it) and fertility (GLP-1s tend to preserve it, unlike testosterone therapy). For women, the front-of-mind issues are contraception and pregnancy (these drugs can undercut the pill and restore fertility, and aren't safe in pregnancy) plus PCOS. Both sexes should protect muscle with strength training and protein.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

4Supporting

Related terms

  • Hypogonadism — A condition of low sex-hormone production. In men it means low testosterone with symptoms; importantly, the low testosterone that often accompanies obesity is frequently a reversible state ('pseudo-hypogonadism') rather than true, pathologic hypogonadism.
  • Testosterone replacement therapy (TRT) — Replacing testosterone in men who have hypogonadism (clinically low testosterone plus symptoms), delivered as a gel, injection, patch, or pellet. It is for a specific diagnosis, not a default treatment for the reversible low testosterone that often accompanies obesity.

Related guides

  • Men's health on a GLP-1: testosterone, fertility, muscle, and the things worth watching — For men, losing weight on a GLP-1 does more than shrink the scale — it can raise testosterone that obesity was quietly suppressing, and unlike testosterone therapy it tends to preserve fertility. Here are the key men's-health angles the research is starting to fill in: the testosterone connection, sexual function and sperm, protecting muscle and bone, cardiovascular benefit, and sleep apnea — plus why the checkup men tend to skip matters more now.
  • HRT for men (testosterone) and GLP-1 medications: what the connection really is — Low testosterone and excess weight are linked — but the arrow often points from weight to testosterone, not the other way, and that changes when testosterone therapy actually helps. Here's who benefits from TRT, and why losing weight on a GLP-1 can raise testosterone on its own.
  • Women's health on a GLP-1: birth control, pregnancy, PCOS, bone, and the things worth watching — For women, a GLP-1 raises questions no man has to think about — the biggest being fertility. These medications can make birth control less reliable and restore ovulation you weren't expecting, so \"Ozempic babies\" are a real phenomenon; they're also not safe in pregnancy. Here are the key women's-health angles: contraception and the pregnancy rules, why GLP-1s often help most in PCOS, protecting bone and muscle, and the menopause overlap.
  • Cortisol, stress, and weight on a GLP-1: what the connection really is — The "cortisol makes you fat" story is mostly overstated. Genuine cortisol excess like Cushing's clearly drives central fat, but everyday stress does far less — and its most underrated relevance on a GLP-1 is muscle, not belly fat. Here's the honest evidence, why sleep is the cortisol lever you actually control, and why "cortisol-blocker" supplements are marketing, not medicine.